Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2600
-0.0076 (-2.84%)
At close: Aug 17, 2026, 4:00 PM EDT
0.2549
-0.0051 (-1.96%)
Pre-market: Aug 18, 2026, 7:15 AM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $10.67 million as of August 18, 2026. Its market cap has decreased by -88.13% in one year.
Market Cap
10.67M
Enterprise Value
-20.28M
1-Year Change
-88.13%
Ranking
Category
Stock Price
$0.26
ChartMarket Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $10.67M, an increase of 14.71%. That is a compound annual growth rate of 1.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 12.00M | -54.02% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 11.33M |
| CytoMed Therapeutics | 11.12M |
| BioVie | 11.01M |
| IN8bio | 10.84M |
| GT Biopharma | 10.82M |
| BioCardia | 10.69M |
| Instinct Bio Technical Company Holdings | 10.42M |
| Theriva Biologics | 10.39M |